These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4686106)

  • 21. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey).
    Bacopoulos NG; Redmond DE; Baulu J; Roth RH
    J Pharmacol Exp Ther; 1980 Jan; 212(1):1-5. PubMed ID: 6766186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioenzymatic paper-chromatographic assay for dopamine and norepinephrine in cerebroventricular cisternal perfusate of cat following administration of cocaine or d-amphetamine.
    Chiueh CC; Kopin IJ
    J Neurochem; 1978 Aug; 31(2):561-4. PubMed ID: 671057
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF; Tan YY; Huang X; Wang Q
    Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous levels and turnover of catecholamines in mouse brain after repeated administration of haloperidol.
    Hyttel J
    Psychopharmacologia; 1974 Apr; 36(3):237-41. PubMed ID: 4846328
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
    Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
    Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Decreased sensitivity of cholecystokinin receptors in the brain as affected by the prolonged administration of haloperidol].
    Vasar EE; Soosaar AKh; Maĭmets MO; Allikmets LKh
    Biull Eksp Biol Med; 1986 Nov; 102(11):583-5. PubMed ID: 3779086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in catecholamine concentrations and synthesis rate in mouse brain during the 'supersensitivity' phase after treatment with neuroleptic drugs.
    Hyttel J; Moller Nielsen I
    J Neurochem; 1976 Jul; 27(1):313-5. PubMed ID: 956841
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of haloperidol on monoamines in brain and heart.
    Falck B; Nordgren L; Rosengren E
    Int J Neuropharmacol; 1969 Dec; 8(6):631-4. PubMed ID: 5363035
    [No Abstract]   [Full Text] [Related]  

  • 34. [Individual variability in the haloperidol response].
    Forsman AO
    Acta Psiquiatr Psicol Am Lat; 1978 Jun; 24(2):149-53. PubMed ID: 753078
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacology and psychiatry.
    Marley E
    Psychol Med; 1972 Aug; 2(3):208. PubMed ID: 4673011
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of 3-hydroxytyramine (dopamine) in human subjects.
    Goodall M; Alton H
    Biochem Pharmacol; 1968 Jun; 17(6):905-14. PubMed ID: 5661353
    [No Abstract]   [Full Text] [Related]  

  • 37. A sensitive enzymatic-isotopic method for the analysis of tyramine in brain and other tissues.
    Tallman JF; Saavedra JM; Axelrod J
    J Neurochem; 1976 Aug; 27(2):465-9. PubMed ID: 965987
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of dopamine dynamics in the brain.
    Wightman RM; May LJ; Michael AC
    Anal Chem; 1988 Jul; 60(13):769A-779A. PubMed ID: 3063135
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine contamination of infused tyramine.
    Holmes C; Moak J; Eldadah B; Zimmerly E; Sharabi Y; Goldstein DS
    Clin Chem; 2005 Sep; 51(9):1733-5. PubMed ID: 16037411
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dopamine in brain function].
    Clouet DH
    Taiwan Yi Xue Hui Za Zhi; 1973 Nov; 72(11):624-32. PubMed ID: 4522050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.